EZHIP
EZH inhibitory protein
Also known as: CATACOMB, CXorf67, EZHIP_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q86X51
- Gene
- EZHIP
- Ensembl
- ENSG00000187690
- Chromosome
- X
- Canonical length
- 503 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
Enables histone methyltransferase inhibitor activity. Involved in epigenetic regulation of gene expression. Located in cytosol and nucleoplasm. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
503 residues, UniProt reviewed canonical sequence.
>Q86X51|EZHIP
1 MATQSDMEKE QKHQQDEGQG GLNNETALAS GDACGTGNQD PAASVTTVSS QASPSGGAAL
61 SSSTAGSSAA AATSAAIFIT DEASGLPIIA AVLTERHSDR QDCRSPHEVF GCVVPEGGSQ
121 AAVGPQKATG HADEHLAQTK SPGNSRRRKQ PCRNQAAPAQ KPPGRRLFPE PLPPSSPGFR
181 PSSYPCSGAS TSSQATQPGP ALLSHASEAR PATRSRITLV ASALRRRASG PGPVIRGCTA
241 QPGPAFPHRA THLDPARLSP ESAPGPARRG RASVPGPARR GCDSAPGPAR RGRDSAPVSA
301 PRGRDSAPGS ARRGRDSAPG PALRVRTARS DAGHRSTSTT PGTGLRSRST QQRSALLSRR
361 SLSGSADENP SCGTGSERLA FQSRSGSPDP EVPSRASPPV WHAVRMRASS PSPPGRFFLP
421 IPQQWDESSS SSYASNSSSP SRSPGLSPSS PSPEFLGLRS ISTPSPESLR YALMPEFYAL
481 SPVPPEEQAE IESTAHPATP PEPLocalizationUniProt · AlphaFold · HPA
Whether an antibody against EZHIP can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.73
- Highest tissue expression
- 5.8 nTPM
Expression across tissuesHPA
Tissue
- testis: 5.8 nTPM
- cerebellum: 1.7 nTPM
- pituitary gland: 0.9 nTPM
- placenta: 0.9 nTPM
- choroid plexus: 0.5 nTPM
- spleen: 0.5 nTPM
Single-cell type
- differentiating spermatogonia: 0.2 nCPM
- early primary spermatocytes: 0.1 nCPM
- undifferentiated spermatogonia: 0.1 nCPM
- adipocytes: 0 nCPM
- adrenal cortex cells: 0 nCPM
- adrenal medulla cells: 0 nCPM
Immune cell
- memory B-cell: 0.1 nTPM
- naive CD4 T-cell: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
Brain region
- hypothalamus: 5 nTPM
- basal ganglia: 3.5 nTPM
- cerebellum: 3.1 nTPM
- cerebral cortex: 3.1 nTPM
- amygdala: 2.9 nTPM
- choroid plexus: 2.9 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0
- gnomAD pLI
- 0
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- histone methyltransferase inhibitor activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of EZHIP in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads EZHIP as an antibody target. Whether an autoantibody or antibody against EZHIP could matter depends on whether native EZHIP is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
EZHIP is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label EZHIP as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...